Shanghai IxCell Biote₹♥>ch Co., Ltd. is a biopharmace•™✔utical company specializing i©ε☆n the development and∞→σ industrial production of c€₹ell-based drugs. With a foc™∑ ≈us on cellular therapeutics, w✔∏'e are dedicated to d×®Ωεelivering high-quality, innovative pδ←₹>roducts. Our core portfolioφ£→ spans three key area δs: mesenchymal stem c∏ ell drugs, induced pluripot☆→€λent stem cell drugs, and immunα✘£e cell drugs. These δ>∑products are supported by aε&ε state-of-the-art cell manufacturin₽™☆←g platform designed to meet the $♠↕highest production standards.
Driven by independent research and a ♣✔¥commitment to innovation, weσ≥↔λ have secured over 40 patents•$ related to cell therapy₩≈ ∏ and have set industry-leadin★≤≈g standards in manufacturing♠¶. Our mesenchymal stem cell↔•∑ drug for the treatme&•♣•nt of knee osteoarthriti™♠s is among the first in China to rea₽↔★ch Phase III clinical trials₽★, positioning it to bΩ&→ecome one of the country’s earliest cφπommercialized stem cel"®♦l therapies.
We operate a 4,000m² GMP-c₩ ompliant production facility l∑↕↔✘ocated in the heart of Zhangji≠≈ ang Hi-Tech Park in Pudong, Shanghai. ¥>This facility integrates b¶¥oth research and manufactσ§↔uring, enabling us to ↕advance our mission of bringin•✔g cutting-edge cell theπ¶rapies to market. The comp£★λ¥any has been recognized with se÷βveral honors, includi ¶♠™ng High-Tech Enterprise, Sha≈₽<≥nghai Specialized and New Small Eλ♥nterprise, and Shanghai Key<♦ Enterprise status.
Industry-Specific Experience
Cellular Manufacturing Facility
Skilled Technical Staff
Patent Portfolio
Our core team is composed of highl↓α¥y accomplished individuals from world-r↓εenowned institutions su"δ₩↔ch as Harvard University↕₩↕ and Yale University, as well as lea₹♦©•ding international companies in☆✔ the cell pharmaceutical indus™∞try. They bring extensive expertise ac÷ ♥ross the entire spectrε×₹um of cell therapy, in α♦cluding mesenchymal stem cells,εγ★ induced pluripotent stem celβ ls, and immune cells. Our team's com≈φ₽↔prehensive experience spans ba × δsic scientific research, ♠"×process development,♣γ₹± large-scale pharmaceutical manufactur™±ing, and navigating the comוδplexities of drug commercialization. Th is diverse and in-depth knowledge posiαδtions us to lead advanceε≠ments in the field of ce↔≠llular medicine.
